Omada Health, Inc. Common Stock OMDA
$20.50
+4.27%
at last close
Analyst Consensus
- Consensus Rating
- Buy (11 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $26.85
- Implied Upside
- +31.0%
- Price Target Range
- $18.00 – $35.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-14 | Freedom Capital MarketsGene Mannheimer |
Maintains | Buy | $35 |
| 2026-09-11 | BarclaysSaket Kalia |
Maintains | Overweight | $25 → $27 |
| 2026-09-11 | NeedhamRyan MacDonald |
Reiterates | Buy | $28 |
| 2026-09-11 | BTIGDavid Larsen |
Reiterates | Buy | $35 |
| 2026-08-14 | JP MorganLisa Gill |
Maintains | Overweight | $26 → $30 |
| 2026-08-14 | CitizensConstantine Davides |
Maintains | Market outperform | $27 → $32 |
| 2026-08-12 | BairdVikram Kesavabhotla |
Maintains | Neutral | $15 → $25 |
| 2026-08-10 | BTIGDavid Larsen |
Maintains | Buy | $30 → $35 |
| 2026-08-03 | BarclaysSaket Kalia |
Maintains | Overweight | $20 → $25 |
| 2026-07-21 | Canaccord GenuityRichard Close |
Maintains | Buy | $24 → $28 |
| 2026-07-20 | CitizensConstantine Davides |
Maintains | Market outperform | $21 → $27 |
| 2026-07-17 | BTIGDavid Larsen |
Initiates coverage on | Buy | $30 |
| 2026-06-22 | Morgan StanleyCraig Hettenbach |
Reiterates | Overweight | $30 |
| 2026-05-08 | BarclaysSaket Kalia |
Maintains | Overweight | $18 → $20 |
| 2026-05-08 | CitizensConstantine Davides |
Maintains | Market outperform | $18 → $21 |
| 2026-05-08 | Evercore ISI GroupElizabeth Anderson |
Maintains | Outperform | $15 → $20 |
| 2026-05-08 | Wells FargoStan Berenshteyn |
Maintains | Equal-weight | $17 → $18 |
| 2026-05-08 | NeedhamRyan MacDonald |
Reiterates | Buy | $28 |
| 2026-04-14 | CitizensConstantine Davides |
Initiates coverage on | Market outperform | $18 |
| 2026-04-09 | Goldman SachsDavid Roman |
Maintains | Buy | $26 → $23 |
| 2026-04-08 | Evercore ISI GroupElizabeth Anderson |
Maintains | Outperform | $20 → $15 |
| 2026-03-12 | JP MorganDestiny Jackson |
Maintains | Overweight | $32 → $26 |
| 2026-03-06 | Canaccord GenuityRichard Close |
Maintains | Buy | $28 → $22 |
| 2026-03-06 | BMO CapitalSean Dodge |
Maintains | Outperform | $27 → $18 |
| 2026-03-06 | Morgan StanleyCraig Hettenbach |
Maintains | Overweight | $32 → $30 |
| 2026-03-06 | BarclaysSaket Kalia |
Maintains | Overweight | $17 → $18 |
| 2026-03-03 | BarclaysSaket Kalia |
Maintains | Overweight | $22 → $17 |
| 2026-01-22 | NeedhamRyan MacDonald |
Reiterates | Buy | $28 |
| 2026-01-09 | Wells FargoStan Berenshteyn |
Initiates coverage on | Equal-weight | $17 |
| 2026-01-05 | BarclaysSaket Kalia |
Maintains | Overweight | $29 → $22 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $20.50
- Market Cap
- $1.20 billion
- 52-Week Range
- $10.28 – $26.91
- Average Volume
- 1.37 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.